Patients require systemic anticoagulation for the duration of the Thoratec VAD support. The Thoratec IVAD is a small, simple and versatile IVAD with the same features as the Thoratec pVAD ...

A centrifugal pump VAD (modified ECMO circuit ... the pump and should mandate comprehensive monitoring and titration of anticoagulation levels. The performance can be adapted by the size of ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, with the late-stage asset tecarfarin, a new ...

PONTE VEDRA, Fla. - Cadrenal Therapeutics, Inc. (NASDAQ: CVKD), a biopharmaceutical company specializing in cardiovascular therapies with a market capitalization of $35.2 million and impressive 210% ...

Cadrenal Therapeutics (CVKD) announced a leadership transition appointing James Ferguson as its new chief medical officer, effective ...

Tecarfarin received Orphan Drug designation (ODD) for advanced heart failure patients with implanted left ventricular assist ... conditions requiring life-long anticoagulation therapy as well ...